Skip to content
healthcare.dev
Get a free key

Enjaymo

NDC 55292-820, sutimlimab-jome, injection, solution, concentrate, from Recordati Rare Diseases, Inc..

Product NDC
55292-820
Status
Listed
Labeler
Recordati Rare Diseases, Inc.
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761164
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55292-820 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SUTIMLIMAB50 mg/mL

Pharmacologic classes

Classical Complement Pathway Inhibitor [EPC]; Classical Complement Pathway Inhibitors [MoA]

Package NDCNDC-11Package
55292-820-01552920820011 VIAL, SINGLE-DOSE in 1 CARTON (55292-820-01) / 22 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0a25363a-7781-d9f8-cb1c-be22987bf03b

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=55292-820

Use it

Look up 55292-820 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55292-820 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55292-820. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.